Introduction {#Sec1}
============

Coronary heart disease (CHD) is a leading cause of morbidity and mortality around the world, with the use of myocardial perfusion imaging (MPI) utilizing SPECT and coronary CT angiogram (cCTA) increasing significantly as a means for non-invasively evaluating patients. However, while MPI is performed for assessing myocardial ischemia, coronary artery stenosis, and coronary arterial anatomy, the incidental detection of extracardiac findings is common. A wide array of incidentally detected pathologies have been reported in the literature, including breast cancer, multiple myeloma, cirrhosis, interstitial lung disease, and pneumonia \[[@CR1]--[@CR6]\]. Extracardiac findings can often be the source of a patient's presumed cardiac symptoms and it is vital for physicians interpreting examinations to evaluate and report said findings. In this article, we report three cases of confirmed COVID-19 infections incidentally detected on coronary dedicate on coronary CT angiography.

Case series {#Sec2}
===========

The first patient is a 60-year-old male with a history of coronary artery bypass graft (CABG) surgery 14 years ago, who presented to cardiology with complaints of chest pain, loss of appetite, nausea, and malaise for 5 days without a reported fever or shortness of breath. His past medical history was also significant for diabetes mellitus type 2 and hypercholesterolemia. He underwent a cCTA which demonstrated geographic areas of basilar and peripheral predominant ground glass opacities with subpleural sparing (Fig. [1a](#Fig1){ref-type="fig"}). The patient's coronary artery bypass grafts were patent without significant stenosis (Fig. [1b](#Fig1){ref-type="fig"}). Shortly after the cCTA, the patient was admitted to the hospital, isolated, and diagnosed with COVID-19 pneumonia. The patient rapidly deteriorated in the hospital, developing acute respiratory distress syndrome (ARDS) and currently is in the intensive care unit (ICU) undergoing treatment.Fig. 1**a** CT angiogram demonstrates patchy peripheral predominant ground glass airspace opacity in the dependent lung segment. There was no evidence of pleural effusion, cavitation, or lymphadenopathy. Findings are typical of COVID-19 pneumonia, and should be included in the differential in geographic areas of disease outbreaks. **b** Coronary artery bypass grafts are patent without significant stenosis

The second patient is a 55-year-old male with no significant past medical history or complaints who presented for cCTA as part of a work-up for an underlying cardiac arrhythmia. The cCTA demonstrated a patchy ground glass opacity within the right lung base (Fig. [2](#Fig2){ref-type="fig"}). The patient subsequently became symptomatic with a fever and cough approximately 48 h after the initial scan, and tested positive for COVID-19 on a real-time polymerase chain reaction (RT-PCR) test.Fig. 2Subpleural focal area of ground glass opacification was incidentally identified at the right lung base without consolidation, cavitation, pleural effusion, or lymphadenopathy. The patient was initially asymptomatic, but developed upper respiratory tract symptoms approximately 48 h after the scan and was subsequently diagnosed with COVID-19 by RT-PCR

The third patient is a 40-year-old female who presented with a few days of shortness of breath and dyspnea on exertion with mild associated chest pain. The patient had no significant past medical history and denied any cough or fevers. Due to the concern for exertional chest pain, the patient underwent a cCTA which demonstrated patent coronary arteries and multifocal, peripheral, lower lobe predominant ground glass opacities, typical of reported CT findings of COVID-19 infection (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3**a**--**c** Multiple bilateral, peripheral, and basilar predominant scattered ground glass opacities are noted. No pleural effusion, consolidation, or lymphadenopathy were detected. **d** The coronary arteries demonstrate no significant atherosclerotic or stenotic disease

Discussion {#Sec3}
==========

COVID-19 was first reported in December 2019 in Wuhan City, China, as a lower respiratory tract illness of unknown origin. Since then, the virus has rapidly spread with over four million confirmed cases of COVID-19 worldwide as of May 17, 2020 \[[@CR7]\]. Although China has been the main country affected by the virus, 64 other countries had confirmed cases of COVID-19, including numerous cases in the United States. Presentations of COVID-19 can vary widely, from completely asymptomatic to severe respiratory syndrome and death. The most common reported symptoms at presentation are fever (43.8% on admission, 88.7% during hospitalization), dry cough, fatigue, sputum production, shortness of breath, sore throat, headache, myalgia/arthralgia, chills, nausea/vomiting, nasal congestion, diarrhea, hemoptysis, and conjunctival congestion \[[@CR8]\]. Patients infected with the virus typically develop signs and symptoms after a mean incubation period of 5--6 days \[[@CR9]--[@CR11]\]. However, the utilization of fever and other typical clinical manifestations of COVID-19 infection, particularly in the very early stages of infection, have been associated with high false-negative rates. Thus, the absence of typical clinical features of COVID-19 is insufficient to exclude the diagnosis in the early stages \[[@CR12]\].

In this article, we report three cases with COVID-19 found incidentally during coronary CT angiography. Patients were referred by their cardiologists for cCTAs due to suspected coronary heart disease, with no clinical suspicion of pneumonia at the time. This highlights the non-specific presentations of COVID-19 infections and difficulty of making the diagnosis on a clinical basis. The typical findings of COVID-19 infection on CT are bilateral peripheral and basilar predominant ground glass opacities and consolidations with extensive geographic distributions \[[@CR13]--[@CR17]\]. Lymphadenopathy and pleural effusions are rare in COVID-19 infections, and are suggestive of an alternative diagnosis. In a study by Pan et al. evaluating the time course of lung changes on CT in patients diagnosed with COVID-19 pneumonia, early CT findings in patients included no findings (17%), a focal area of ground glass or consolidation (42%), and multilobe opacities (42%), with a peripheral predominance for airspace opacities \[[@CR15]\]. The patients in our case series demonstrated similar early CT findings, underlining the importance of including COVID-19 on the differential in at-risk patients with incidentally detected suspicious patterns of airway disease. Furthermore, the typical demographic of patients undergoing myocardial perfusion imaging are elderly with underlying medical co-morbidities. These patients have shown to be at the highest risk for developing complications related to COVID-19 infection, with increased rates of ICU admissions and mortality \[[@CR18], [@CR19]\], stressing the need for early recognition and treatment of COVID-19 in this high-risk demographic.

The detection of incidental extracardiac findings on cCTAs is common and the evaluation and reporting of extracardiac findings should be performed on every myocardial perfusion study \[[@CR20]--[@CR22]\]. In a review of the literature discussing the incidental extracardiac findings on cCTA, a total of 13 articles were found including a total of 13,995 patients. Incidental extracardiac findings were detected in 4286 of these patients (30.6%) encompassing a wide array of pathologies, including the diagnosis of lung, adrenal, hepatic, and osseous malignancies (Table [1](#Tab1){ref-type="table"}). In addition, similar rates of extracardiac findings have been reported in cardiac magnetic resonance imaging (cMRI) \[[@CR34]\] and myocardial perfusion SPECT imaging \[[@CR35]\]. A recent publication by Ai et al. demonstrated chest CT to have a higher sensitivity for the diagnosis of COVID-19 than initial RT-PCR tests, suggesting chest CT may be used as a primary method for diagnosis in epidemic areas \[[@CR36]\]. This is likely in part due to the reported low sensitivity of the RT-PCR test for COVID-19, ranging around 60--70%, requiring multiple tests to confidently rule out the diagnosis \[[@CR37]\]. Thus, knowledge of the typical and early imaging findings of COVID-19 infections is crucial to ensure appropriate early diagnosis.Table 1Incidental extracardiac findings in coronary CT angiographic studiesAuthorsYear of publicationNo. of patientsNo. of findingsIncidental extracardiac findingsChristoph l. Lee \[[@CR23]\]2010151102Pulmonary nodule ≥ 4 mm, interstitial lung disease, equivocal liver lesion, lung consolidation, gynecomastia, cholelithiasis, compressed bronchus, marked mediastinal lymphadenopathy, pleural effusion, marked ascites, moderate hiatal hernia, multinodular goiter, pulmonary nodule \< 4 mm, calcified granulomata, fissure opacity or atelectasis, benign hepatic cyst, simple renal cyst, small hiatal hernia, pleural calcification, benign adrenal adenoma, pectus deformity, hamartoma in the lungJay Koonce \[[@CR24]\]20081764507Aneurysm, pulmonary embolism, adenopathy, cyst, mass, nodules, pneumonia, interstitial disease, airways disease, atelectasis, emphysema, pleural effusion and plaque, breast mass, thyroid mass, bone metastasis, hepatic cyst, indeterminate liver, liver mass, adrenal mass, miscellaneous findingsVikram Venkatesh, MD \[[@CR25]\]20108067Lung/mediastinum: suspicious pulmonary nodule, pulmonary fibrosis, benign nodule/granuloma bulla, pleural plaques atelectasis/scar lymph nodesLiver: indeterminate lesions, cyst, steatosisKidney: indeterminate lesion, cyst, calculi, atrophyGallbladder: calculiSpleen: granulomaVascular: anatomic variant, ectatic/atheromatous aortaGastrointestinal: hiatus herniaAdrenal: indeterminate lesion, adenomaOlga Lazoura, MD \[[@CR26]\]20101044729Abdominal: hepatic steatosis, liver cyst, liver hemangioma, liver echinococcus cyst, calcified liver granuloma, calcified splenic granuloma, ascites, abdominal aortic aneurysm, liver massThoracic: emphysema, hiatus hernia, calcified lung granuloma, bone hemangioma, calcified lymph nodes, bronchiectasis, remote fracture, substernal thyroid, pulmonary nodule, thoracic adenopathy, pleural effusion, atelectasis, consolidation/GGO, pleural thickening, mediastinal mass lesions, interstitial lung disease, ascending aortic aneurysm, dilated aortic root, pulmonary hypertension, pulmonary embolusIman Aglan \[[@CR27]\]2009542391Aorta: ascending aortic aneurysm, ascending aortic ectasia, atherosclerosis, atheroma, supradiaphragmal kinkingPulmonary vessels: pulmonary artery ectasia, supernumerary pulmonary vein ("top roof vein")Pleura: effusion, nodular thickeningLung parenchyma: infiltrate, post-inflammatory changes, atypical pneumonia, intrapulmonary non-specific nodules, calcified/non-calcified granuloma, central bronchial neoplasm, emphysema, dystelectasisBronchi: ectasia, wall thickening, indeterminate intraluminal structureLymph node: lymphadenopathy, calcificationLiver: steatosis hepatis, non-specific hypodense liver lesion, cystGallbladder: cholecystolithiasisSpleen: calcificationMiscellaneous: gastric bulging and mucosal hypertrophy, axial hiatal hernia, severe diaphragmatic elevationPow-Li chia \[[@CR28]\]20091061103Liver tumors, cysts, and hemangiomas; hepatic steatosis; pneumobilia; pulmonary nodules; emphysema; interstitial lung disease; histiocytosis; pneumonia, including tuberculosis; pleural effusion; pulmonary edema; aortic aneurysms, pulmonary embolism; ascites; breast cancer; adrenal hyperplasia; lymphomaSam J. Lehman \[[@CR29]\]2009395205Lungs: non-calcified pulmonary nodule, calcified pulmonary nodule, pulmonary infiltrate, emphysema, atelectasis, pleural effusion, enlarged hilar or mediastinal lymph node, pneumothoraxAbdomen: liver cyst, contrast-enhancing liver lesion, fatty liver, hiatus hernia, contrast-enhancing splenic lesion, gallstonesAorta: aneurysm, dissection, penetrating aortic ulcerMiscellaneous: hemangioma of the spinal column, thyroid mass, chest wall mass, hemangiomaJin Woo Kim \[[@CR30]\]2009254282Lungs and mediastinum: pulmonary nodule, consolidation/ground glass opacity, interstitial lung disease, emphysema, bronchiectasis, fibrotic scar/air cyst, pleural thickening/calcification, mediastinal mass/lymphadenopathy, pleural effusionAorta: aortic aneurysm/dissectionYoshiyoki Kawano \[[@CR31]\]2007617149Lung, thyroid and hepatic cancer, post-inflammatory lung nodules, hepatic cysts/hemangiomas, benign thyroid tumors, mediastinal lymphadenopathies, benign mammary gland tumors, esophageal submucosal tumorJeffrey Mueller \[[@CR32]\]200725951Pulmonary nodule pneumonia, large mucous plug, pulmonary embolism, aortic ulcer or aneurysm, adrenal mass, moderate pleural effusion, sternal dehiscence, mediastinitis, sarcoidosis, pulmonary hypertension, moderate-sized pneumothoraxSabine Haller \[[@CR33]\]200616636Emphysema, hernia, lymphadenopathy, aortic aneurysm, arteria lusoria, bronchiectasis, nerve root cyst, pleural calcification, severe spondylosis, pulmonary fibrosis, bronchial carcinoma, pneumonia, pulmonary emboli, benign pulmonary mass

Conclusion {#Sec4}
==========

The interpretation of a coronary CT angiogram should not be limited to the evaluation of coronary arteries. With the growing incidence of COVID-19, radiologists and cardiologists interpreting cCTAs should be aware of the imaging features of the SARS-CoV-2 infection. In epidemic areas, COVID-19 should be included in the differential diagnosis in patients with suspicious imaging features, for which constant vigilance is vital. Although the full-field-of-view reconstructions are not incorporated in CCTA protocols of many imaging centers, they should be routinely reviewed as a part of image interpretation. Multiple prior studies have emphasized the importance of full-field-of-view images in identifying major extracardiac findings \[[@CR38], [@CR39]\]. Hence, we strongly recommend the inclusion of full-field-of-view images in CCTA protocols in daily practice, as this may lead to the detection of crucial non-cardiac pathologies. Very high clinical index of suspicion and a very low threshold for clinical and paraclinical screening and diagnostic testing, such as PCR and CT chest, allows earlier recognition, detection, and treatment of this potentially life-threatening and devastating disease and can help ensure appropriate post-exposure precautions are implemented.
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